JP2017509689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509689A5 JP2017509689A5 JP2016562463A JP2016562463A JP2017509689A5 JP 2017509689 A5 JP2017509689 A5 JP 2017509689A5 JP 2016562463 A JP2016562463 A JP 2016562463A JP 2016562463 A JP2016562463 A JP 2016562463A JP 2017509689 A5 JP2017509689 A5 JP 2017509689A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- independently hydrogen
- carbon atoms
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 60
- 229910052739 hydrogen Inorganic materials 0.000 claims 44
- 239000001257 hydrogen Substances 0.000 claims 42
- 125000005842 heteroatom Chemical group 0.000 claims 35
- 229910052760 oxygen Inorganic materials 0.000 claims 32
- 229910052717 sulfur Inorganic materials 0.000 claims 32
- 125000004432 carbon atom Chemical group C* 0.000 claims 29
- 125000000623 heterocyclic group Chemical group 0.000 claims 29
- 150000002431 hydrogen Chemical class 0.000 claims 28
- 125000005843 halogen group Chemical group 0.000 claims 21
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 18
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 10
- 229910052799 carbon Inorganic materials 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 125000002837 carbocyclic group Chemical group 0.000 claims 8
- 150000001721 carbon Chemical group 0.000 claims 8
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 7
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 125000001960 7 membered carbocyclic group Chemical group 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- -1 CF 3 Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000024340 acute graft versus host disease Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461923906P | 2014-01-06 | 2014-01-06 | |
| US61/923,906 | 2014-01-06 | ||
| PCT/US2015/010084 WO2015103507A1 (en) | 2014-01-06 | 2015-01-05 | Cyclohexyl sulfone rorϒ modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017509689A JP2017509689A (ja) | 2017-04-06 |
| JP2017509689A5 true JP2017509689A5 (enExample) | 2018-02-15 |
| JP6548664B2 JP6548664B2 (ja) | 2019-07-24 |
Family
ID=52392245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562463A Expired - Fee Related JP6548664B2 (ja) | 2014-01-06 | 2015-01-05 | シクロヘキシルスルホンＲＯＲγ調節因子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9708253B2 (enExample) |
| EP (1) | EP3092215B1 (enExample) |
| JP (1) | JP6548664B2 (enExample) |
| CN (1) | CN106061947B (enExample) |
| ES (1) | ES2704460T3 (enExample) |
| WO (1) | WO2015103507A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9663469B2 (en) | 2013-09-09 | 2017-05-30 | Bristol-Myers Squibb Company | RORγ modulators |
| WO2015042212A1 (en) | 2013-09-20 | 2015-03-26 | Bristol-Myers Squibb Company | RORγ MODULATORS |
| EP3092215B1 (en) | 2014-01-06 | 2018-10-17 | Bristol-Myers Squibb Company | Cyclohexyl sulfone ror gamma modulators |
| WO2015103508A1 (en) | 2014-01-06 | 2015-07-09 | Bristol-Myers Squibb Company | CARBOCYCLIC SULFONE RORγ MODULATORS |
| JP6476205B2 (ja) | 2014-01-06 | 2019-02-27 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＲＯＲγ修飾因子としてのヘテロ環式スルホン |
| CN106061971B (zh) | 2014-01-06 | 2019-03-12 | 百时美施贵宝公司 | 吡咯烷基砜衍生物及其作为RORγ调节剂的用途 |
| ES2767303T3 (es) | 2014-10-30 | 2020-06-17 | Janssen Pharmaceutica Nv | Tiazoles sustituidos por amida como moduladores de Rorgamma T |
| JOP20200117A1 (ar) | 2014-10-30 | 2017-06-16 | Janssen Pharmaceutica Nv | كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t |
| BR112017008842A2 (pt) | 2014-10-30 | 2017-12-26 | Janssen Pharmaceutica Nv | tiazóis como moduladores de ror?t |
| ES2887087T3 (es) | 2015-05-07 | 2021-12-21 | Bristol Myers Squibb Co | Sulfonas tricíclicas como moduladores ROR gamma |
| TWI691486B (zh) | 2016-01-29 | 2020-04-21 | 日商東麗股份有限公司 | 環狀胺衍生物及其醫藥用途 |
| TW201803869A (zh) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 作為ＲＯＲγＴ調節劑之６－胺基吡啶－３－基噻唑 |
| TW201821404A (zh) * | 2016-11-09 | 2018-06-16 | 美商必治妥美雅史谷比公司 | 作為ROR γ調節劑之三環碸 |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
| WO2019007284A1 (zh) * | 2017-07-01 | 2019-01-10 | 复旦大学 | 咔唑酰胺类衍生物或其盐及其制备方法和用途 |
| KR20200033224A (ko) * | 2017-07-27 | 2020-03-27 | 도레이 카부시키가이샤 | 원형 탈모증의 치료제 또는 예방제 |
| WO2019022234A1 (ja) * | 2017-07-27 | 2019-01-31 | 東レ株式会社 | 炎症性腸疾患の治療剤又は予防剤 |
| EP3807251B1 (en) | 2018-06-18 | 2022-09-07 | Janssen Pharmaceutica NV | Phenyl and pyridinyl substituted imidazoles as modulators of roryt |
| US10975057B2 (en) | 2018-06-18 | 2021-04-13 | Janssen Pharmaceutica Nv | 6-aminopyridin-3-yl pyrazoles as modulators of RORgT |
| JP2021528405A (ja) | 2018-06-18 | 2021-10-21 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲγｔのモジュレータとしてのアミド置換チアゾール |
| JP2021529161A (ja) | 2018-06-18 | 2021-10-28 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲγｔのモジュレーターとしてのピリジニルピラゾール |
| CN112513021B (zh) * | 2018-07-10 | 2023-06-27 | 广东东阳光药业有限公司 | RORγ拮抗剂及其在药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2456420A1 (en) * | 2001-08-21 | 2003-03-06 | Merck Sharp & Dohme Limited | Novel cyclohexyl sulphones |
| GB0223039D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| GB0513747D0 (en) * | 2005-07-06 | 2005-08-10 | Merck Sharp & Dohme | Therapeutic compounds |
| WO2012158784A2 (en) * | 2011-05-16 | 2012-11-22 | Theodore Mark Kamenecka | Modulators of the nuclear hormone receptor ror |
| US9216988B2 (en) * | 2011-12-22 | 2015-12-22 | Genentech, Inc. | Benzyl sulfonamide derivatives as RORc modulators |
| US20130190356A1 (en) * | 2011-12-22 | 2013-07-25 | Genentech, Inc. | Benzyl sulfonamide derivatives as rorc modulators |
| AU2013259904A1 (en) | 2012-05-08 | 2014-10-02 | Lycera Corporation | Bicyclic sulfone compounds for inhibition of RORy activity and the treatment of disease |
| CA2871514C (en) * | 2012-05-08 | 2020-08-25 | Merck Sharp & Dohme Corp. | Tetrahydronaphthyridine and related bicyclic compounds for inhibition of ror.gamma.activity and the treatment of disease |
| WO2014028669A1 (en) * | 2012-08-15 | 2014-02-20 | Biogen Idec Ma Inc. | Novel compounds for modulation of ror-gamma activity |
| US10035790B2 (en) | 2012-10-19 | 2018-07-31 | Exelixis, Inc. | RORγ modulators |
| US9663469B2 (en) | 2013-09-09 | 2017-05-30 | Bristol-Myers Squibb Company | RORγ modulators |
| WO2015042212A1 (en) | 2013-09-20 | 2015-03-26 | Bristol-Myers Squibb Company | RORγ MODULATORS |
| CN106061971B (zh) * | 2014-01-06 | 2019-03-12 | 百时美施贵宝公司 | 吡咯烷基砜衍生物及其作为RORγ调节剂的用途 |
| WO2015103508A1 (en) | 2014-01-06 | 2015-07-09 | Bristol-Myers Squibb Company | CARBOCYCLIC SULFONE RORγ MODULATORS |
| EP3092215B1 (en) | 2014-01-06 | 2018-10-17 | Bristol-Myers Squibb Company | Cyclohexyl sulfone ror gamma modulators |
| JP6476205B2 (ja) * | 2014-01-06 | 2019-02-27 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＲＯＲγ修飾因子としてのヘテロ環式スルホン |
-
2015
- 2015-01-05 EP EP15700816.0A patent/EP3092215B1/en not_active Not-in-force
- 2015-01-05 WO PCT/US2015/010084 patent/WO2015103507A1/en not_active Ceased
- 2015-01-05 ES ES15700816T patent/ES2704460T3/es active Active
- 2015-01-05 CN CN201580012008.2A patent/CN106061947B/zh not_active Expired - Fee Related
- 2015-01-05 US US15/109,733 patent/US9708253B2/en active Active
- 2015-01-05 JP JP2016562463A patent/JP6548664B2/ja not_active Expired - Fee Related